Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of Gracell Biotechnologies Inc. from Q4 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Gracell Biotechnologies Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q4 2021 to Q2 2023.
  • Gracell Biotechnologies Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Jun 2023 was $224K.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)

Gracell Biotechnologies Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 $224K +$224K 30 Jun 2023 6-K 14 Aug 2023
Q4 2022 $235K +$235K 31 Dec 2022 20-F 25 Apr 2023
Q2 2022 $0 30 Jun 2022 6-K 15 Aug 2022
Q4 2021 $0 31 Dec 2021 20-F 22 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.